As the world’s population continues to encounter SARS-CoV-2 virus and become infected, one question…

Researchers find first strong genetic risk factor for disorder

Starting a lab is hard enough. Now do it in a pandemic.

SARS-CoV-2 variants are evolving new ways to evade antibodies, vaccines

International search focused on scientific achievement, commitment to HMS values

Findings reveal insights about the evolution of gut microbes in response to diet and environment

How SARS-CoV-2 mutations allow the virus to dodge immune defenses

How exactly does SARS-CoV-2 cause disease?

Analysis points to a new culprit in the spread of a common intestinal infection.

$30 million commitment to support research collaboration with HMS toward therapeutic development

Harvard Medical School has received a $5 million gift for Lyme disease research and education